Search

everythinglearnresearchcommunity

for

Search:↓

Epimedium extract helps increase skin pigmentation and could be a new treatment for conditions with reduced pigmentation.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Hair aging is caused by stress, hormones, inflammation, and DNA damage affecting hair growth and color.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

Stem cells help repair tissue mainly by releasing beneficial substances, not by replacing damaged cells.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Porcine skin is very similar to human skin, making it a useful model for research.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Tofacitinib is an effective and safe treatment for alopecia areata.

CTLA4 gene variants are not linked to alopecia areata in Monterrey's Mexican population.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Light therapy can effectively treat vitiligo and hair loss caused by a specific medication.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Apremilast did not work for treating severe alopecia areata.

The silk fibroin-based hydrogel shows promise for treating melanoma and healing infected wounds by killing tumor cells and bacteria, and supporting skin recovery.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

A girl with severe hair loss saw hair regrowth after using cannabis.